ORPHA:59
Allan-Herndon-Dudley syndrome
Also known as: AHDS · MCT8 deficiency · Monocarboxylate transporter 8 deficiency · X-linked intellectual disability-hypotonia syndrome
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
688
89.8th percentile
Trials
4
Interventional, condition-specific
Researchers
1,059
Distinct authors in sample
Gene link
SLC16A2
Definitive
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
A rare X-linked syndromic with neuromuscular involvement characterized by a varying degree of neurodevelopmental delay including , hypokinesia, dystonia and spasticity, and a wide range of clinical sequelae secondary to chronic peripheral thyrotoxicosis.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010354
- MeSH:C537047
- OMIM:300523
- UMLS:C0795889
- NCIT:C118843
Additional Mondo synonyms (4)
ALLAN-Herndon syndrome · MCT8-Specific Thyroid Hormone Cell Transporter Deficiency · MCT8-specific thyroid hormone cell Membrane transporter deficiency · monocarboxylate transporter 8 deficiency
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — SLC16A2
- LiteraturePresent
688 matched papers (471 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
4 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (SLC16A2).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
688
688 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
688 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
471 in the last 10 years · medium confidence · 89.8th percentile (publications denominator)
Phrase hits: 688 · MeSH hits: 0
Who's working on it?
1,059
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Visser WE22 papers · 2026
Academic Center for Thyroid Diseases, Erasmus Medical Centre, Rotterdam, Netherlands. Electronic address: w.e.visser@erasmusmc.nl.
Papers in Europe PMC - 02Heuer H20 papers · 2026
Department of Endocrinology, University of Duisburg-Essen, University Hospital Essen, D-45147 Essen, Germany.
Papers in Europe PMC - 03Groeneweg S14 papers · 2025
Academic Center for Thyroid Diseases, Erasmus Medical Centre, Rotterdam, Netherlands.
Papers in Europe PMC - 04Mayerl S12 papers · 2026
Department of Endocrinology, University of Duisburg-Essen, University Hospital Essen, D-45147 Essen, Germany.
Papers in Europe PMC - 05Krude H11 papers · 2025
Department of Paediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Papers in Europe PMC - 06Peeters RP10 papers · 2026
Academic Center for Thyroid Diseases, Erasmus Medical Centre, Rotterdam, Netherlands.
Papers in Europe PMC - 07Tonduti D10 papers · 2026
Unit of Pediatric Neurology, C.O.A.L.A. (Center for Diagnosis and Treatment of Leukodystrophies), V. Buzzi Children's Hospital, Milan, Italy.
Papers in Europe PMC - 08van Geest FS10 papers · 2025
Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, GD Rotterdam, The Netherlands.
Papers in Europe PMC - 09Guadaño-Ferraz A9 papers · 2025
Department of Endocrine and Nervous System Pathophysiology, Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Papers in Europe PMC - 10Refetoff S9 papers · 2025
Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
4
interventional trials for this specific condition
4 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 27 July 2026
4 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 86.7th percentile).
medium confidence · 86.7th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
4 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
5 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT04463316·RECRUITING·GROWing Up With Rare GENEtic Syndromes
Conditions: Prader-Willi Syndrome · PWS-like Syndrome · Silver Russel Syndrome · Congenital Hypopituitarism·Matched via name phrase
- NCT03047369·RECRUITING·The Myelin Disorders Biorepository Project
Conditions: Leukodystrophy · White Matter Disease · Leukoencephalopathies · 4H Syndrome·Matched via name phrase
- NCT06566066·RECRUITING·Register for Patients With Thyroid Hormone Resistance.
Conditions: Hypothyroidism · Global Developmental Delay · Intellectual Disability · Dystonia·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Allan-Herndon-Dudley syndrome" OR "MCT8 deficiency" OR "Monocarboxylate transporter 8 deficiency" OR "X-linked intellectual disability-hypotonia syndrome" OR "ALLAN-Herndon syndrome" OR "MCT8-Specific Thyroid Hormone Cell Transporter Deficiency" OR "MCT8-specific thyroid hormone cell Membrane transporter deficiency"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Allan-Herndon-Dudley syndrome" OR "MCT8 deficiency" OR "Monocarboxylate transporter 8 deficiency" OR "X-linked intellectual disability-hypotonia syndrome" OR "ALLAN-Herndon syndrome" OR "MCT8-Specific Thyroid Hormone Cell Transporter Deficiency" OR "MCT8-specific thyroid hormone cell Membrane transporter deficiency" OR "SLC16A2"
Recall-expansion terms: SLC16A2
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 4 interventional · 5 observational · 2 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: AHDS
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T12:16:26.166Z
